Author:
Salah-Uddin Hasib,Gordon Margaret J.,Ford Isobel,Tandon Narendra N.,Greaves Mike,Duttaroy Asim K.
Reference50 articles.
1. Cortelazzo S, Viero P, Barbui T: Platelets activation in myeloproliferative disorders. Thromb Haemost 45: 211–213, 1981
2. Duttaroy AK: Insulin mediated processes in platelets, monocytes/ macrophages and crythrocytes: Effects of essential fatty acid metabolism. Prost Leuk Essntl Fatty Acids 51: 385–389, 1994
3. Wchmeicr A, Sudhoff T, Meierkord F: Relation of platelet abnormalities to thrombosis and hemorrhage in chronic course of myeloproliferative disorders. Eur J Haematol 45: 191–197, 1997
4. Landolfi R, Ciabattoni G, Patrignani P, Castellana MAL, Pogliani E, Bizzi B, Patrono C: Increased thromboxane biosynthesis in patients with polycythemia vera: Evidence for aspirin-suppressible platelet activation in vivo. Blood 80: 1965–1971, 1992
5. Van Gendcren PJJ, Prins FJ, Michiels JJ, Schror K: Thromboxanedependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: As an antithrombotic agent. Br J Haematol 104: 438–441, 1999